:

Chandra Kumar Krishnan1, Madhusudan Reddy Karagiri2, Venkatraman Radhakrishnan3

  • 1Department of Surgical Oncology, Cancer Institute (WIA), No: 38, Sardar Patel Road, Adyar, Chennai, 600036 India.

概括

骨髓瘤新辅助化疗 (NACT) 期间的临床进展表明结果不佳. 然而,在本研究中,这种进展并不是总体存活率或无病存活率的显著预测因素.